Fig. 4
From: Modulation of cancer signalling pathway(s) in two -stage mouse skin tumorigenesis by annonacin
Micrograph of H&E sections from mice kidney treated with (a) acetone (Group I, vehicle control); (b) DMBA/TPA (Group II, carcinogen control); (c) 85 nM annonacin (Group III, treatment); (d) 85 nM annonacin only (Group IV, treatment control); (e) 10 mg/kg curcumin (Group V, reference). Note: inflammation (i), degeneration (d), Bowman‘s capsule dilatation (bd), glomerular cellularity (gc), glomerulus (g) and Bowman’s capsule (b). Magnification × 100